Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Zoek op
Notre engagement
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Werken bij Boehringer Ingelheim
Werken bij Boehringer Ingelheim
Nevenwerking
Nevenwerking
Nevenwerking-melden
Nevenwerking-melden
Contacteer ons
Contacteer ons
Raad van Bestuur
Raad van Bestuur
Chronische Nierziekte
Chronische Nierziekte
Retinale aandoeningen
Retinale aandoeningen
Veterinaire volksgezondheid
Veterinaire volksgezondheid
Gedragscode
Code of Conduct
Transparantie
Transparantie
Aftopor®/Aftovaxpur®/Aftovax®/Aftobov®Oleosa/Aftovaxpur®Doe
FMD vaccines with highly potent and purified antigens (Aftopor®, Aftovaxpur®, Aftobov® Oleosa) allow differentiation between infected and vaccinated animals for endemic or emergency situations.
Arti-Cell® FORTE
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
Aservo® EquiHaler®
Aservo® EquiHaler®
Wetenschappelijke verhalen
Click here to view our latest science success stories. It's important to reflect on the success of new medicines making patients lives significantly better.
Psychische stoornissen
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Producten voor menselijke gezondheid
Products Overview of our products.
Schizofrenie
Schizophrenia
Depressie
Depression
Borderline persoonlijkheidsstoornis
Borderline Personality Disorder
NASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim.
onze verhalen
Our Stories
EFPIA-openbaarmaking
Openbaarmaking van dochterondernemingen van Boehringer Ingelheim in landen met EFPIA-ledenverenigingen.
BI PRIVACYVERKLARING
Privacy HCPs and customers